Inmune Bio, Inc. (INMB) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2017: $309.7K2018: $823.8K2019: $860.5K2020: $1.90M2021: $19.72M2022: $21.69M2023: $18.86M2024: $7.46M2025: $8.83M$8.83M
2017Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$8.83M+18.2%
2024$7.46M-60.4%
2023$18.86M-13.0%
2022$21.69M+10.0%
2021$19.72M+936.8%
2020$1.90M+121.0%
2019$860.5K+4.5%
2018$823.8K+166.0%
2017$309.7K